Cancer Diagnostics Research Innovations的封面图片
Cancer Diagnostics Research Innovations

Cancer Diagnostics Research Innovations

研究服务

Dallas，TX 32 位关注者

HIGHER EFFICACY. LARGER SAMPLING. PROVEN VALIDATION. SIMPLY BETTER.

关注

关于我们

HIGHER EFFICACY. LARGER SAMPLING. PROVEN VALIDATION. SIMPLY BETTER. CRDI owns patented technology acquired from leaders in the discovery, development, and validation of biomarkers for cancer risk and early detection. We are poised to license our technology in hopes of commercializing products to improve health outcomes for the greater cancer community. CURRENT AREAS OF FOCUS ARE: GASTRIC CANCER | ESOPHAGEAL CANCER | ULCERATIVE COLITIS

网站
https://cancerdiagnosticsresearch.com/
所属行业
研究服务
规模
2-10 人
总部
Dallas，TX
类型
私人持股
创立
2022
领域
Intellectual Property、Technology Transfer、IP Licensing、Liquid Biopsy、Cancer Early Detection和Blood Test

地点

相似主页